Managers / Q1 2024 · view latest →
GLENVIEW CAPITAL MANAGEMENT, LLC
CIK 0001138995 · 520 MADISON AVENUE, 33RD FLOOR, NEW YORK, NY, 10022 · 2128124700
Reported Value
$5.7B
Q1 2024
Positions
45
Filings on Record
32
2019–present window
Filed
May 15, 2024
original filing
Summary
Glenview Capital Management, LLC reported $5.7B in U.S.-listed holdings across 45 positions for Q1 2024.
Its largest position, THC, represents 11.6% of the portfolio.
Compared with Q4 2023, the fund opened 7 new positions and exited 4.
Reported Value by Quarter
13F Reported Value
Portfolio Composition
By security type
- Common Stock · 84.5% · $4.8B
- ETP · 10.3% · $588M
- Other · 3.4% · $194M
- ADR · 1.9% · $106M
- Equity WRT · 0.0% · $77,271
Quarter-over-Quarter Changes full breakdown →
vs Q4 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| SPDR S&P 500 ETF TR | NEW | +660.0K | 660.0K | +$345M | $345M |
| ARRYARRAY TECHNOLOGIES INC | NEW | +2.20M | 2.20M | +$33M | $33M |
| GINKGO BIOWORKS HOLDINGS INC | NEW | +24.00M | 24.00M | +$28M | $28M |
| AVGOBROADCOM INC | NEW | +20.0K | 20.0K | +$27M | $27M |
| CUCAAVIS BUDGET GROUP | NEW | +181.0K | 181.0K | +$22M | $22M |
| EXKEXACT SCIENCES CORP | NEW | +227.6K | 227.6K | +$16M | $16M |
| WWAYFAIR INC | NEW | +219.7K | 219.7K | +$15M | $15M |
| MRVLMARVELL TECHNOLOGY INC | ADDED | +1.19M | 1.37M | +$86M | $97M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2024
42 positions
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | THCTENET HEALTHCARE CORP | COM NEW | 11.63% | $665M | 6.33M |
| 2 | CITHE CIGNA GROUP | COM | 9.35% | $534M | 1.47M |
| 3 | CTVACORTEVA INC | COM | 6.84% | $391M | 6.79M |
| 4 | UHSUNIVERSAL HLTH SVCS INC | CL B | 6.55% | $375M | 2.05M |
| 5 | GPNGLOBAL PMTS INC | COM | 5.58% | $319M | 2.39M |
| 6 | ALITEURALIGHT INC | COM CL A | 4.88% | $279M | 28.32M |
| 7 | DXCDXC TECHNOLOGY CO | COM | 4.74% | $271M | 12.78M |
| 8 | PAHUSDELEMENT SOLUTIONS INC | COM | 3.65% | $209M | 8.36M |
| 9 | CLARIVATE PLC | ORD SHS | 3.20% | $183M | 24.65M |
| 10 | MCKMCKESSON CORP | COM | 2.70% | $155M | 288.0K |
| 11 | USFDUS FOODS HLDG CORP | COM | 2.38% | $136M | 2.52M |
| 12 | CVSCVS HEALTH CORP | COM | 2.37% | $135M | 1.70M |
| 13 | FISVFISERV INC | COM | 2.24% | $128M | 802.7K |
| 14 | TEVATEVA PHARMACEUTICAL INDS LTD | SPONSORED ADS | 1.85% | $106M | 7.50M |
| 15 | MYGNMYRIAD GENETICS INC | COM | 1.84% | $105M | 4.94M |
| 16 | MRVLMARVELL TECHNOLOGY INC | COM | 1.70% | $97M | 1.37M |
| 17 | B7SBROOKDALE SR LIVING INC | COM | 1.67% | $95M | 14.44M |
| 18 | ELVELEVANCE HEALTH INC | COM | 1.58% | $90M | 174.2K |
| 19 | UBERUBER TECHNOLOGIES INC | COM | 1.52% | $87M | 1.13M |
| 20 | EXPEEXPEDIA GROUP INC | COM NEW | 1.48% | $85M | 614.4K |
| 21 | KNXKNIGHT-SWIFT TRANSN HLDGS IN | CL A | 1.27% | $73M | 1.33M |
| 22 | VVVVALVOLINE INC | COM | 1.27% | $73M | 1.63M |
| 23 | AMZNAMAZON COM INC | COM | 1.27% | $73M | 402.9K |
| 24 | HCAHCA HEALTHCARE INC | COM | 1.14% | $65M | 195.6K |
| 25 | VTRSVIATRIS INC | COM | 1.07% | $61M | 5.14M |
| 26 | METAMETA PLATFORMS INC | CL A | 0.93% | $53M | 109.3K |
| 27 | BCBRUNSWICK CORP | COM | 0.81% | $46M | 480.5K |
| 28 | DNBDUN & BRADSTREET HLDGS INC | COM | 0.63% | $36M | 3.61M |
| 29 | ARRYARRAY TECHNOLOGIES INC | COM SHS | 0.57% | $33M | 2.20M |
| 30 | GINKGO BIOWORKS HOLDINGS INC | CL A SHS | 0.49% | $28M | 24.00M |
| 31 | AVGOBROADCOM INC | COM | 0.46% | $27M | 20.0K |
| 32 | EVLVEVOLV TECHNOLOGIES HLDNGS IN | COM CL A | 0.46% | $26M | 5.95M |
| 33 | CUCAAVIS BUDGET GROUP | COM | 0.39% | $22M | 181.0K |
| 34 | EXKEXACT SCIENCES CORP | COM | 0.27% | $16M | 227.6K |
| 35 | WWAYFAIR INC | CL A | 0.26% | $15M | 219.7K |
| 36 | OFIXORTHOFIX MED INC | COM | 0.22% | $13M | 883.1K |
| 37 | BFLYBUTTERFLY NETWORK INC | COM CL A · *W EXP 02/12/202 | 0.15% | $9M | 9.75M |
| 38 | DIGIMARC CORP NEW | COM | 0.14% | $8M | 291.9K |
| 39 | LIBERTY GLOBAL LTD | COM CL A | 0.05% | $3M | 176.1K |
| 40 | CBUSCIBUS INC | CL A COM STK | 0.05% | $3M | 116.5K |
| 41 | RPIDRAPID MICRO BIOSYSTEMS INC | CLASS A COM | 0.02% | $1M | 1.32M |
| 42 | DOMA HOLDINGS INC | COM NEW | 0.00% | $72,613 | 16.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $4.0B | 44 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $4.9B | 57 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $4.5B | 54 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $3.6B | 43 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $4.1B | 45 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $4.0B | 36 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $5.2B | 46 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $5.1B | 48 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $5.7B | 45 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $4.7B | 44 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $4.4B | 52 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $4.4B | 49 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $4.6B | 54 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $4.5B | 53 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $4.0B | 54 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $4.0B | 55 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $4.9B | 60 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021REVEALED | $6.1B | 67 | Feb 18, 2022 | RESTATEMENT | changes · EDGAR ↗ |
| Q3 2021 | $5.5B | 59 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $6.0B | 64 | Aug 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $5.9B | 63 | May 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $4.4B | 56 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $3.2B | 45 | Nov 16, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $3.6B | 44 | Aug 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $3.7B | 44 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $11.4B | 50 | Feb 14, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $9.5B | 49 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $11.0B | 46 | Aug 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $11.2B | 45 | May 15, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $10.3B | 50 | Feb 14, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.